Proteomics and metabolomics in psychiatry:
Gespeichert in:
| Weitere Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Basel
Karger
[2014]
|
| Schriftenreihe: | Advances in biological psychiatry
v. 29 |
| Schlagworte: | |
| Beschreibung: | Description based on print version record |
| Beschreibung: | 1 online resource (vii, 142 pages) iIlustrations |
| ISBN: | 9783318026009 331802600X |
Internformat
MARC
| LEADER | 00000nmm a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV044358427 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 170620s2014 |||| o||u| ||||||eng d | ||
| 020 | |a 9783318026009 |c electronic bk. |9 978-3-318-02600-9 | ||
| 020 | |a 331802600X |c electronic bk. |9 3-318-02600-X | ||
| 035 | |a (ZDB-4-NLEBK)ocn882106770 | ||
| 035 | |a (OCoLC)882106770 | ||
| 035 | |a (DE-599)BVBBV044358427 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 082 | 0 | |a 616.89 |2 23 | |
| 245 | 1 | 0 | |a Proteomics and metabolomics in psychiatry |c volume editor, Daniel Martins-de-Souza |
| 264 | 1 | |a Basel |b Karger |c [2014] | |
| 300 | |a 1 online resource (vii, 142 pages) |b iIlustrations | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Advances in biological psychiatry |v v. 29 | |
| 500 | |a Description based on print version record | ||
| 505 | 8 | |a Proteomic characterization of the brain and cerebrospinal fluid of schizophrenia patients / Caf-Mendes, C.C.; Gattaz, W.F.; Schmitt, A.; Britto, L.R.G.; Martins-de-Souza, D -- Peripheral biomarker candidates in schizophrenia / Thome, J.; Bratek, A.; Krysta, K -- Schizophrenia : blood-serum-plasma metabolomics / Lista, S.; Giegling, I.; Rujescu, D -- Proteomic and metabolomic evidence for glial alterations in schizophrenia / Beasley, C.L.; Barakauskas, V.E -- Insights from proteomic studies on schizophrenia preclinical models : what can we learn for drug discovery? / Farrelly, L.A.; Föcking, M.; Cotter, D.R -- Metabolomics to study psychotic disorders and their metabolic comorbidities / Oresi, M -- Peripheral biomarkers for depression by plasma and serum proteomics / Domenici, E -- Proteomics of preclinical models of depression / Carboni, L -- Antidepressant response metabonomics / Qin, X.; Gao, X.; Qiao, Y.; Zhou, Y.; Tian, J.; Li, Z -- Proteomics and metabolomics of bipolar disorder / Sussulini, A -- Use of metabolomics and proteomics to reveal pathophysiological pathways in anxiety disorders / Altmaier, E.; Emeny, R.T. | |
| 505 | 8 | |a This publication compiles data generated by proteomics and metabolomics about psychiatric disorders. Leading researchers in these fields review the basic principles of proteomics and metabolomics and propose the new directions to be followed in molecular psychiatry. The chapters divided into two sections - Schizophrenia/Psychotic Disorders and Mood Disorders - deal with findings in diverse tissues from human and preclinical models in order to unravel the biology and biochemistry behind the establishment and course of these illnesses as well as potential biomarkers for clinical applications. More than an update, this publication indicates the next steps to discover biomarkers and understand psychiatric disorders more comprehensively.This publication is valuable reading for psychiatrists, neuroscientists and analytical chemists interested in the basics of proteomics and metabolomics, psychiatric definitions and the most advanced hypotheses about the pathobiology of schizophrenia, depression and bipolar disorder | |
| 650 | 7 | |a HEALTH & FITNESS / Diseases / General |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Clinical Medicine |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Diseases |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Evidence-Based Medicine |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Internal Medicine |2 bisacsh | |
| 650 | 7 | |a Mental illness / Etiology |2 fast | |
| 650 | 4 | |a Mental Disorders / etiology | |
| 650 | 4 | |a Biomarkers | |
| 650 | 4 | |a Mental Disorders / diagnosis | |
| 650 | 4 | |a Mental Disorders / physiopathology | |
| 650 | 4 | |a Metabolomics / methods | |
| 650 | 4 | |a Proteomics / methods | |
| 650 | 4 | |a Evidenz-basierte Medizin | |
| 650 | 4 | |a Innere Medizin | |
| 650 | 4 | |a Medizin | |
| 650 | 4 | |a Mental illness |x Etiology | |
| 650 | 0 | 7 | |a Psychische Störung |0 (DE-588)4047686-8 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Proteomanalyse |0 (DE-588)4596545-6 |2 gnd |9 rswk-swf |
| 655 | 7 | |8 1\p |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 689 | 0 | 0 | |a Psychische Störung |0 (DE-588)4047686-8 |D s |
| 689 | 0 | 1 | |a Proteomanalyse |0 (DE-588)4596545-6 |D s |
| 689 | 0 | |8 2\p |5 DE-604 | |
| 700 | 1 | |a Martins-de-Souza, Daniel |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |t Proteomics and metabolomics in psychiatry |z 9783318025996 |
| 912 | |a ZDB-4-NLEBK | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-029761058 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 2\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
Datensatz im Suchindex
| _version_ | 1804177604182278144 |
|---|---|
| any_adam_object | |
| author2 | Martins-de-Souza, Daniel |
| author2_role | edt |
| author2_variant | d m d dmd |
| author_facet | Martins-de-Souza, Daniel |
| building | Verbundindex |
| bvnumber | BV044358427 |
| collection | ZDB-4-NLEBK |
| contents | Proteomic characterization of the brain and cerebrospinal fluid of schizophrenia patients / Caf-Mendes, C.C.; Gattaz, W.F.; Schmitt, A.; Britto, L.R.G.; Martins-de-Souza, D -- Peripheral biomarker candidates in schizophrenia / Thome, J.; Bratek, A.; Krysta, K -- Schizophrenia : blood-serum-plasma metabolomics / Lista, S.; Giegling, I.; Rujescu, D -- Proteomic and metabolomic evidence for glial alterations in schizophrenia / Beasley, C.L.; Barakauskas, V.E -- Insights from proteomic studies on schizophrenia preclinical models : what can we learn for drug discovery? / Farrelly, L.A.; Föcking, M.; Cotter, D.R -- Metabolomics to study psychotic disorders and their metabolic comorbidities / Oresi, M -- Peripheral biomarkers for depression by plasma and serum proteomics / Domenici, E -- Proteomics of preclinical models of depression / Carboni, L -- Antidepressant response metabonomics / Qin, X.; Gao, X.; Qiao, Y.; Zhou, Y.; Tian, J.; Li, Z -- Proteomics and metabolomics of bipolar disorder / Sussulini, A -- Use of metabolomics and proteomics to reveal pathophysiological pathways in anxiety disorders / Altmaier, E.; Emeny, R.T. This publication compiles data generated by proteomics and metabolomics about psychiatric disorders. Leading researchers in these fields review the basic principles of proteomics and metabolomics and propose the new directions to be followed in molecular psychiatry. The chapters divided into two sections - Schizophrenia/Psychotic Disorders and Mood Disorders - deal with findings in diverse tissues from human and preclinical models in order to unravel the biology and biochemistry behind the establishment and course of these illnesses as well as potential biomarkers for clinical applications. More than an update, this publication indicates the next steps to discover biomarkers and understand psychiatric disorders more comprehensively.This publication is valuable reading for psychiatrists, neuroscientists and analytical chemists interested in the basics of proteomics and metabolomics, psychiatric definitions and the most advanced hypotheses about the pathobiology of schizophrenia, depression and bipolar disorder |
| ctrlnum | (ZDB-4-NLEBK)ocn882106770 (OCoLC)882106770 (DE-599)BVBBV044358427 |
| dewey-full | 616.89 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.89 |
| dewey-search | 616.89 |
| dewey-sort | 3616.89 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04550nmm a2200637zcb4500</leader><controlfield tag="001">BV044358427</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">170620s2014 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783318026009</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-3-318-02600-9</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">331802600X</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">3-318-02600-X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-4-NLEBK)ocn882106770</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)882106770</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV044358427</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.89</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Proteomics and metabolomics in psychiatry</subfield><subfield code="c">volume editor, Daniel Martins-de-Souza</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel</subfield><subfield code="b">Karger</subfield><subfield code="c">[2014]</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (vii, 142 pages)</subfield><subfield code="b">iIlustrations</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Advances in biological psychiatry</subfield><subfield code="v">v. 29</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Description based on print version record</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Proteomic characterization of the brain and cerebrospinal fluid of schizophrenia patients / Caf-Mendes, C.C.; Gattaz, W.F.; Schmitt, A.; Britto, L.R.G.; Martins-de-Souza, D -- Peripheral biomarker candidates in schizophrenia / Thome, J.; Bratek, A.; Krysta, K -- Schizophrenia : blood-serum-plasma metabolomics / Lista, S.; Giegling, I.; Rujescu, D -- Proteomic and metabolomic evidence for glial alterations in schizophrenia / Beasley, C.L.; Barakauskas, V.E -- Insights from proteomic studies on schizophrenia preclinical models : what can we learn for drug discovery? / Farrelly, L.A.; Föcking, M.; Cotter, D.R -- Metabolomics to study psychotic disorders and their metabolic comorbidities / Oresi, M -- Peripheral biomarkers for depression by plasma and serum proteomics / Domenici, E -- Proteomics of preclinical models of depression / Carboni, L -- Antidepressant response metabonomics / Qin, X.; Gao, X.; Qiao, Y.; Zhou, Y.; Tian, J.; Li, Z -- Proteomics and metabolomics of bipolar disorder / Sussulini, A -- Use of metabolomics and proteomics to reveal pathophysiological pathways in anxiety disorders / Altmaier, E.; Emeny, R.T.</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">This publication compiles data generated by proteomics and metabolomics about psychiatric disorders. Leading researchers in these fields review the basic principles of proteomics and metabolomics and propose the new directions to be followed in molecular psychiatry. The chapters divided into two sections - Schizophrenia/Psychotic Disorders and Mood Disorders - deal with findings in diverse tissues from human and preclinical models in order to unravel the biology and biochemistry behind the establishment and course of these illnesses as well as potential biomarkers for clinical applications. More than an update, this publication indicates the next steps to discover biomarkers and understand psychiatric disorders more comprehensively.This publication is valuable reading for psychiatrists, neuroscientists and analytical chemists interested in the basics of proteomics and metabolomics, psychiatric definitions and the most advanced hypotheses about the pathobiology of schizophrenia, depression and bipolar disorder</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HEALTH & FITNESS / Diseases / General</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Clinical Medicine</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Diseases</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Evidence-Based Medicine</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Internal Medicine</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Mental illness / Etiology</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Mental Disorders / etiology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biomarkers</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Mental Disorders / diagnosis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Mental Disorders / physiopathology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Metabolomics / methods</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Proteomics / methods</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Evidenz-basierte Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Innere Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Mental illness</subfield><subfield code="x">Etiology</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Psychische Störung</subfield><subfield code="0">(DE-588)4047686-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Proteomanalyse</subfield><subfield code="0">(DE-588)4596545-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="8">1\p</subfield><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Psychische Störung</subfield><subfield code="0">(DE-588)4047686-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Proteomanalyse</subfield><subfield code="0">(DE-588)4596545-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">2\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Martins-de-Souza, Daniel</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="t">Proteomics and metabolomics in psychiatry</subfield><subfield code="z">9783318025996</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-NLEBK</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029761058</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield></record></collection> |
| genre | 1\p (DE-588)4143413-4 Aufsatzsammlung gnd-content |
| genre_facet | Aufsatzsammlung |
| id | DE-604.BV044358427 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:50:43Z |
| institution | BVB |
| isbn | 9783318026009 331802600X |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029761058 |
| oclc_num | 882106770 |
| open_access_boolean | |
| physical | 1 online resource (vii, 142 pages) iIlustrations |
| psigel | ZDB-4-NLEBK |
| publishDate | 2014 |
| publishDateSearch | 2014 |
| publishDateSort | 2014 |
| publisher | Karger |
| record_format | marc |
| series2 | Advances in biological psychiatry |
| spelling | Proteomics and metabolomics in psychiatry volume editor, Daniel Martins-de-Souza Basel Karger [2014] 1 online resource (vii, 142 pages) iIlustrations txt rdacontent c rdamedia cr rdacarrier Advances in biological psychiatry v. 29 Description based on print version record Proteomic characterization of the brain and cerebrospinal fluid of schizophrenia patients / Caf-Mendes, C.C.; Gattaz, W.F.; Schmitt, A.; Britto, L.R.G.; Martins-de-Souza, D -- Peripheral biomarker candidates in schizophrenia / Thome, J.; Bratek, A.; Krysta, K -- Schizophrenia : blood-serum-plasma metabolomics / Lista, S.; Giegling, I.; Rujescu, D -- Proteomic and metabolomic evidence for glial alterations in schizophrenia / Beasley, C.L.; Barakauskas, V.E -- Insights from proteomic studies on schizophrenia preclinical models : what can we learn for drug discovery? / Farrelly, L.A.; Föcking, M.; Cotter, D.R -- Metabolomics to study psychotic disorders and their metabolic comorbidities / Oresi, M -- Peripheral biomarkers for depression by plasma and serum proteomics / Domenici, E -- Proteomics of preclinical models of depression / Carboni, L -- Antidepressant response metabonomics / Qin, X.; Gao, X.; Qiao, Y.; Zhou, Y.; Tian, J.; Li, Z -- Proteomics and metabolomics of bipolar disorder / Sussulini, A -- Use of metabolomics and proteomics to reveal pathophysiological pathways in anxiety disorders / Altmaier, E.; Emeny, R.T. This publication compiles data generated by proteomics and metabolomics about psychiatric disorders. Leading researchers in these fields review the basic principles of proteomics and metabolomics and propose the new directions to be followed in molecular psychiatry. The chapters divided into two sections - Schizophrenia/Psychotic Disorders and Mood Disorders - deal with findings in diverse tissues from human and preclinical models in order to unravel the biology and biochemistry behind the establishment and course of these illnesses as well as potential biomarkers for clinical applications. More than an update, this publication indicates the next steps to discover biomarkers and understand psychiatric disorders more comprehensively.This publication is valuable reading for psychiatrists, neuroscientists and analytical chemists interested in the basics of proteomics and metabolomics, psychiatric definitions and the most advanced hypotheses about the pathobiology of schizophrenia, depression and bipolar disorder HEALTH & FITNESS / Diseases / General bisacsh MEDICAL / Clinical Medicine bisacsh MEDICAL / Diseases bisacsh MEDICAL / Evidence-Based Medicine bisacsh MEDICAL / Internal Medicine bisacsh Mental illness / Etiology fast Mental Disorders / etiology Biomarkers Mental Disorders / diagnosis Mental Disorders / physiopathology Metabolomics / methods Proteomics / methods Evidenz-basierte Medizin Innere Medizin Medizin Mental illness Etiology Psychische Störung (DE-588)4047686-8 gnd rswk-swf Proteomanalyse (DE-588)4596545-6 gnd rswk-swf 1\p (DE-588)4143413-4 Aufsatzsammlung gnd-content Psychische Störung (DE-588)4047686-8 s Proteomanalyse (DE-588)4596545-6 s 2\p DE-604 Martins-de-Souza, Daniel edt Erscheint auch als Druck-Ausgabe Proteomics and metabolomics in psychiatry 9783318025996 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Proteomics and metabolomics in psychiatry Proteomic characterization of the brain and cerebrospinal fluid of schizophrenia patients / Caf-Mendes, C.C.; Gattaz, W.F.; Schmitt, A.; Britto, L.R.G.; Martins-de-Souza, D -- Peripheral biomarker candidates in schizophrenia / Thome, J.; Bratek, A.; Krysta, K -- Schizophrenia : blood-serum-plasma metabolomics / Lista, S.; Giegling, I.; Rujescu, D -- Proteomic and metabolomic evidence for glial alterations in schizophrenia / Beasley, C.L.; Barakauskas, V.E -- Insights from proteomic studies on schizophrenia preclinical models : what can we learn for drug discovery? / Farrelly, L.A.; Föcking, M.; Cotter, D.R -- Metabolomics to study psychotic disorders and their metabolic comorbidities / Oresi, M -- Peripheral biomarkers for depression by plasma and serum proteomics / Domenici, E -- Proteomics of preclinical models of depression / Carboni, L -- Antidepressant response metabonomics / Qin, X.; Gao, X.; Qiao, Y.; Zhou, Y.; Tian, J.; Li, Z -- Proteomics and metabolomics of bipolar disorder / Sussulini, A -- Use of metabolomics and proteomics to reveal pathophysiological pathways in anxiety disorders / Altmaier, E.; Emeny, R.T. This publication compiles data generated by proteomics and metabolomics about psychiatric disorders. Leading researchers in these fields review the basic principles of proteomics and metabolomics and propose the new directions to be followed in molecular psychiatry. The chapters divided into two sections - Schizophrenia/Psychotic Disorders and Mood Disorders - deal with findings in diverse tissues from human and preclinical models in order to unravel the biology and biochemistry behind the establishment and course of these illnesses as well as potential biomarkers for clinical applications. More than an update, this publication indicates the next steps to discover biomarkers and understand psychiatric disorders more comprehensively.This publication is valuable reading for psychiatrists, neuroscientists and analytical chemists interested in the basics of proteomics and metabolomics, psychiatric definitions and the most advanced hypotheses about the pathobiology of schizophrenia, depression and bipolar disorder HEALTH & FITNESS / Diseases / General bisacsh MEDICAL / Clinical Medicine bisacsh MEDICAL / Diseases bisacsh MEDICAL / Evidence-Based Medicine bisacsh MEDICAL / Internal Medicine bisacsh Mental illness / Etiology fast Mental Disorders / etiology Biomarkers Mental Disorders / diagnosis Mental Disorders / physiopathology Metabolomics / methods Proteomics / methods Evidenz-basierte Medizin Innere Medizin Medizin Mental illness Etiology Psychische Störung (DE-588)4047686-8 gnd Proteomanalyse (DE-588)4596545-6 gnd |
| subject_GND | (DE-588)4047686-8 (DE-588)4596545-6 (DE-588)4143413-4 |
| title | Proteomics and metabolomics in psychiatry |
| title_auth | Proteomics and metabolomics in psychiatry |
| title_exact_search | Proteomics and metabolomics in psychiatry |
| title_full | Proteomics and metabolomics in psychiatry volume editor, Daniel Martins-de-Souza |
| title_fullStr | Proteomics and metabolomics in psychiatry volume editor, Daniel Martins-de-Souza |
| title_full_unstemmed | Proteomics and metabolomics in psychiatry volume editor, Daniel Martins-de-Souza |
| title_short | Proteomics and metabolomics in psychiatry |
| title_sort | proteomics and metabolomics in psychiatry |
| topic | HEALTH & FITNESS / Diseases / General bisacsh MEDICAL / Clinical Medicine bisacsh MEDICAL / Diseases bisacsh MEDICAL / Evidence-Based Medicine bisacsh MEDICAL / Internal Medicine bisacsh Mental illness / Etiology fast Mental Disorders / etiology Biomarkers Mental Disorders / diagnosis Mental Disorders / physiopathology Metabolomics / methods Proteomics / methods Evidenz-basierte Medizin Innere Medizin Medizin Mental illness Etiology Psychische Störung (DE-588)4047686-8 gnd Proteomanalyse (DE-588)4596545-6 gnd |
| topic_facet | HEALTH & FITNESS / Diseases / General MEDICAL / Clinical Medicine MEDICAL / Diseases MEDICAL / Evidence-Based Medicine MEDICAL / Internal Medicine Mental illness / Etiology Mental Disorders / etiology Biomarkers Mental Disorders / diagnosis Mental Disorders / physiopathology Metabolomics / methods Proteomics / methods Evidenz-basierte Medizin Innere Medizin Medizin Mental illness Etiology Psychische Störung Proteomanalyse Aufsatzsammlung |
| work_keys_str_mv | AT martinsdesouzadaniel proteomicsandmetabolomicsinpsychiatry |